Scientists often claim to be rational in their purchase decisions and consider only price, availability or quality. But for more than 20 years we at BioInformatics LLC have argued that brand awareness, perceptions and loyalty have a very influential role in scientists’ decisions about which instruments and consumables they will purchase for their labs.
In our most recent report we explore the market for Clustered Regularly Interspaced Short Palindromic Repeats, or more popularly “CRISPR”, is a simple yet powerful genome editing technique that has recently taken the scientific community by storm. When coupled with the Cas9 protein, the technology allows for specific changes (addition, modification and deletions) to be […]
The 2017 Market for NGS Informatics: Probing the Commercial Landscape is designed to help companies navigate the crowded market for products and services that support Next Generation Sequencing (NGS) data analysis and storage. Scientists face many challenges when choosing a solution: it is often difficult to determine the significance of results, the storage space needed […]
According to China’s FDA (CFDA), the State Council issued two five-year plans on food and drug safety earlier this year that will impact analytical instrument manufacturers. In regards to food safety, violation laws and quality standards will be much stricter, with over 300 national standards for consumer foods, agricultural products and pesticides to be issued […]
In both our 2017 Global Assessment Report: The Analytical and Life Science Instrument Market and our survey of life science lab budgets we reported that Asian markets were growing faster than scientific markets in the US and Europe. Chinese in particular is of great interest to our clients and we will soon be publishing a […]
The market for antibodies currently has a very large number of suppliers. Given the importance of trust in this particular market, it is not surprising that leading suppliers invest heavily in order to develop enduring brand loyalty. In our report, The 2017 Market for Research Antibodies: Keys to Success for Commercial Suppliers, one of the […]
We’ve long known that scientific customers can exhibit remarkable brand loyalty. When we ask what made you choose this product over another, the answer is consistently “It’s what has worked for me in the past” or “It was recommended to me by a colleague.” Such was the case when we last explored the antibody market […]
Current indications are that India will have the strongest regional market for life science and analytical instrumentation and lab products in 2017, with growth forecast at 7.5%, followed closely by China at 6.8%. Both countries continue to develop rapidly with private and public investments, but the Chinese market has grown to such a size that […]
Since 2015, BioInformatics LLC has been collecting valuable end-user data on the markets for Real-Time PCR, Cell-Based Assays and CRISPR/Cas9 Products & Services. While companies often measure brand performance overall, it is important to remember that perceptions of your brand can vary widely across different market segments. We have just published a complimentary report comparing […]
“A word about scientists. I want to emphasize at the outset that, contrary to popular belief, scientists are not detached observers of nature and the facts they discover are not simply inherent in the natural phenomena they observe. Scientists construct facts by constantly making decisions about what they will consider significant, what experiments they should […]
Pay Invoice
Latest Blogs
-
The Strategic Edge: How Custom Competitive Intelligence (CI) Research Fuels Growth in Life Sciences
February 13, 2025 1:33 pm
-
Assessing the Value of Product Attributes: Deciphering Consumer Preferences
April 25, 2024 10:28 am
-
How Market Research Supercharges Life Sciences Go-To-Market Strategies
April 24, 2024 12:34 pm
Sitemap
Your Data and Privacy
About Us
BioInformatics, part of the Science and Medicine Group, is the leading research and advisory firm serving the life science and diagnostic industries. Our expertise includes primary quantitative and qualitative research in addition to secondary research and published reports. We own a proprietary, international community of more than 55,000 scientists and biomedical researchers to provide insights that grow businesses and move markets. Our multi-disciplinary team is comprised of industry veterans, market research experts, and survey statisticians.